[ T able_StockInfo] 2024 年 08 月 26 日 证券研究报告•2024 年半年报点评 买入 （维持） 当前价：3.77 元 海油发展（600968）石油石化 目标价：——元（6 个月） 重点项目有序推进，24H1 业绩符合预期 [Table_Summary 事件：公司发布] 2024 年半年报。2024H1，公司实现营业收入 216.3 亿元，同 比增长 4.7%；归母净利润 16.2亿元，同比增长 20.9%。2024Q2，公司实现营 业收入 124.3亿元，同比增长 11.7%；归母净利润 11.2亿元，同比增长 20.7%。 利润端增长显著。 受益于中海油增储上产，工作量持续放量增长。2024H1，能源技术服务产业营 收 77.8 亿，同比+20.1%，其中井下工具业务工作量同比+14.5%，人工举升服 务工作量同比+24.9%，油田化学服务工作量同比+5.5%，装备设计制造及运维 服务工作量同比+6.7%；低碳环保与数字化服务产业营收 34.8亿，同比+2.9%， 其中安全技术、应急、技能提升业务工作量同比+28.8%，数字化业务工作量同 比+7.4%；能源物流服务产业营收 ...

Investment Rating - Buy (Maintained) [1] Core Views - The company's 24H1 performance was under pressure, with equipment orders increasing by 26.8% YoY [1] - Gas business accounted for a larger proportion, with excellent profitability [1] - Gas business grew steadily, with equipment sales orders increasing by 26.8% YoY [1] - Compressor and nitric acid unit technologies are internationally leading, with smooth expansion of compressed air energy storage business [1] - The company is expected to achieve a net profit attributable to the parent company of 11.2, 12.6, and 14.3 billion yuan from 2024 to 2026, with a compound growth rate of 12% [1] Financial Performance - 24H1 revenue was 5.0 billion yuan, a decrease of 3.5% YoY [1] - Net profit attributable to the parent company was 460 million yuan, a decrease of 13.3% YoY [1] - Single 24Q2 revenue was 2.51 billion yuan, a decrease of 0.4% YoY and an increase of 0.8% QoQ [1] - Net profit attributable to the parent company in 24Q2 was 220 million yuan, a decrease of 16.0% YoY and a decrease of 4.6% QoQ [1] - Comprehensive gross margin in 24H1 was 23.4%, a decrease of 0.58pp YoY [1] - Net profit margin in 24H1 was 10.4%, a decrease of 0.56pp YoY [1] - Period expense ratio in 24H1 was 9.0%, an increase of 0.70pp YoY [1] Business Segments - Gas business revenue in 24H1 was 1.87 billion yuan, an increase of 17.4% YoY [1] - Gas business gross margin increased by 1.4pp to 17.7% [1] - Liquid production increased by 8.78% compared to the same period in 2023, reaching a historical high [1] - Energy conversion equipment revenue was 2.65 billion yuan, a decrease of 15.9% YoY [1] - Energy conversion system service revenue was 490 million yuan, a decrease of 47.5% YoY [1] Technological Advancements - The company successfully broke the monopoly of foreign companies in the marine platform centrifugal compressor market [1] - Developed a centrifugal compressor suitable for small and medium-sized medium-pressure nitric acid plants [1] - The company has a 10MW-400MW compressed air energy storage system solution [1] - Successfully completed the trial run and grid connection of the world's first 300MW compressed air energy storage power station [1] Financial Forecast - Expected net profit attributable to the parent company from 2024 to 2026 is 11.2, 12.6, and 14.3 billion yuan [1] - Current stock price corresponds to a PE of 11, 10, and 9 times [1] - Compound growth rate of net profit attributable to the parent company over the next three years is 12% [1]

Investment Rating - The report does not specify a clear investment rating for the company [1]. Core Views - The company reported a revenue of 1.66 billion yuan in the first half of 2024, a year-on-year decline of 4.6%, while the net profit attributable to shareholders was 200 million yuan, an increase of 10.3% [2][9]. - The company plans to distribute a cash dividend of 3 yuan per 10 shares to all shareholders [2]. - The company has successfully opened its first overseas store in Melbourne, Australia, marking the beginning of its international expansion [2][5]. Revenue and Profitability - The company achieved a gross margin of 24.8% in the first half of 2024, an increase of 3.7 percentage points year-on-year, primarily due to lower raw material prices [2][9]. - The net profit margin for the first half of 2024 was 12%, up 1.8 percentage points year-on-year, indicating a recovery to a higher level of profitability [2][9]. - The company expects revenues for 2024-2026 to be 35.83 billion yuan, 39.26 billion yuan, and 42.61 billion yuan, respectively, with corresponding net profits of 3.78 billion yuan, 4.22 billion yuan, and 4.55 billion yuan [1][20]. Business Segmentation - Revenue from fresh products, pre-packaged, and other products in the first half of 2024 was 1.39 billion yuan (down 6.5%) and 180 million yuan (up 4.1%), respectively [2][9]. - The company operates primarily through a distribution model, with revenue from distribution channels accounting for 84.7% of total revenue in the first half of 2024 [11]. - The company has a total of 6,308 domestic stores as of the end of the first half of 2024, an increase of 103 stores since the beginning of the year [2][13]. Financial Forecasts - The company forecasts earnings per share (EPS) of 0.91 yuan, 1.01 yuan, and 1.10 yuan for 2024, 2025, and 2026, respectively, with corresponding dynamic price-to-earnings (PE) ratios of 16, 14, and 13 [1][20]. - The company anticipates a gradual improvement in average store revenue, with expected growth rates of -3%, 6%, and 5% for 2024-2026 [17].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 28.60 CNY over the next six months [1][6]. Core Insights - The company reported a robust revenue growth of 22.93% year-on-year for H1 2024, achieving a total revenue of 2.771 billion CNY. However, net profit increased only by 1.84% to 216 million CNY, primarily due to increased R&D expenses [1]. - The company's vehicle power supply products generated 2.324 billion CNY in revenue, representing a 15.20% year-on-year growth, accounting for 83.86% of total revenue. The overall gross margin for these products stood at 20.63% [1]. - The electric drive system products saw a significant revenue increase of 299.99% year-on-year, reaching 285 million CNY, with the integrated electric drive products growing by 368.24% to 206 million CNY [1]. - The company is actively expanding its overseas customer base, with export revenue of 268 million CNY in H1 2024, although this represents a decline of 16.49% year-on-year [1]. - Increased R&D investment reached 179 million CNY, a 62.43% increase year-on-year, which contributed to a higher expense ratio [1]. - The company forecasts a compound annual growth rate (CAGR) of 18.3% for net profit from 2024 to 2026, with expected net profits of 550 million CNY, 710 million CNY, and 830 million CNY for those years respectively [1][5]. Summary by Sections Financial Performance - H1 2024 revenue: 2.771 billion CNY, up 22.93% YoY - H1 2024 net profit: 216 million CNY, up 1.84% YoY - Q2 2024 revenue: 1.404 billion CNY, up 15.98% QoQ - Q2 2024 net profit: 102 million CNY, down 17.91% QoQ [1]. Business Segments - Vehicle power supply revenue: 2.324 billion CNY, up 15.20% YoY, with a gross margin of 20.63% - Electric drive system revenue: 285 million CNY, up 299.99% YoY, with integrated products at 206 million CNY, up 368.24% YoY [1]. - Export revenue: 268 million CNY, down 16.49% YoY, accounting for 9.66% of total revenue [1]. R&D and Future Outlook - R&D expenses: 179 million CNY, up 62.43% YoY, representing 6.45% of total revenue - Expected net profits for 2024-2026: 550 million CNY, 710 million CNY, 830 million CNY, with a CAGR of 18.3% [1][5].

Investment Rating - The report maintains a "Buy" rating for the company [1][2]. Core Insights - The company achieved a revenue of 3.13 billion yuan in the first half of 2024, representing a year-on-year growth of 2.3%. However, the net profit attributable to shareholders decreased by 4.3% to 460 million yuan [1]. - In Q2 2024, the revenue was 1.62 billion yuan, showing a year-on-year increase of 2.0% and a quarter-on-quarter increase of 7.5%. The net profit for this quarter was 230 million yuan, down 13.2% year-on-year but up 0.7% quarter-on-quarter [1]. - Domestic revenue grew by 3.2% year-on-year, while overseas revenue fell by 12.8%, primarily due to a high base in 2023. The company is seeing a shift in its downstream application sectors, with the proportion of revenue from new energy and chemical industries declining [1]. - The overall gross margin for the first half of 2024 was 29.4%, down 3.0 percentage points year-on-year, attributed to price reductions on some products. The net profit margin was 14.7%, a decrease of 1.0 percentage points year-on-year [1]. - The company is expected to benefit from domestic equipment upgrades and overseas market expansion, with the overseas market potentially being 2-3 times the size of the domestic market [1]. Financial Forecast and Valuation - The forecast for net profit attributable to shareholders for 2024-2026 is 1.08 billion yuan, 1.23 billion yuan, and 1.38 billion yuan, respectively, with an expected compound annual growth rate (CAGR) of 11.1% [2]. - The earnings per share (EPS) for the same period is projected to be 1.88 yuan, 2.13 yuan, and 2.40 yuan [2]. - The company’s price-to-earnings (PE) ratio is expected to decrease from 9 in 2024 to 7 in 2026, indicating a potentially attractive valuation [3].

Investment Rating - The report maintains a "Buy" rating for China National Heavy Duty Truck Group Co., Ltd. (3808.HK) [1] Core Views - The company reported a revenue of 48.82 billion yuan for the first half of 2024, representing an 18.0% year-on-year increase, and a net profit attributable to shareholders of 3.29 billion yuan, up 39.7% year-on-year [2] - The company has proposed a mid-term dividend plan, with a proposed payout of 0.66 yuan per share, resulting in a total dividend of approximately 1.82 billion yuan, which reflects a 55% payout ratio [2] - The company is capitalizing on the structural opportunities in the heavy truck market, particularly in the natural gas segment, achieving a 273% year-on-year increase in natural gas heavy truck sales, with a market share of 25.6% [2] - The export of heavy trucks has also seen a positive trend, with the company exporting 68,000 units in the first half of 2024, accounting for over 40% of the market share [2] - The company is enhancing its competitive advantage in the new energy vehicle sector, with a 309% year-on-year increase in sales of new energy heavy trucks [3] Summary by Sections Financial Performance - For the first half of 2024, the company achieved a revenue of 48.82 billion yuan and a net profit of 3.29 billion yuan, with respective year-on-year growth rates of 18.0% and 39.7% [2] - The company forecasts net profits of 6.50 billion, 7.19 billion, and 8.20 billion yuan for 2024, 2025, and 2026, respectively, with corresponding PE ratios of 8, 7, and 6 [3] Market Position - The company has solidified its leading position in the heavy truck market, with a total heavy truck sales volume of 125,000 units in the first half of 2024, reflecting a 14.8% year-on-year increase [2] - The market share for heavy trucks reached 24.8%, an increase of 2.5 percentage points year-on-year [2] Strategic Initiatives - The company is focusing on the new energy vehicle market, with significant growth in both heavy and light new energy trucks, and has introduced a new 612kWh dump truck with a real-world range exceeding 400 kilometers [3] - The company aims to leverage its strong product competitiveness and distribution capabilities to capture a more significant share of the new energy market [3]

[Table_StockInfo] 2024 年 08 月 26 日 证券研究报告•2024 年半年报点评 买入 （维持） 当前价：46.48 元 恒立液压（601100）机械设备 目标价：——元（6 个月） 多元化布局稳步推进，24Q2 业绩超预期 [Table_Summary] 事件：公司发布 2024年半年报，24H1实现营收 48.3亿元，同比+8.6%；归母 净利润 12.9 亿元，同比+0.7%；单 24Q2 实现营收 24.7 亿元，同比+22.1%， 环比+4.7%，实现归母净利润 6.9 亿元，同比+5.0%，环比+14.0%。多元化布 局稳步推进，24Q2 业绩超预期。 受汇兑收益波动影响，公司净利率承压小幅下滑。24H1,公司综合毛利率为 41.6%，同比+2.6pp，主要系原材料成本下降、业务结构优化等影响；净利率为 26.7%，同比-2.1pp；期间费用率为 11.5%，同比+5.2pp，其中，销售、管理、 研发和财务费用率分别同比+0.38pp、+0.85pp、-0.64pp、+4.56pp，财务费用 率提升主要系汇兑收益较上年同期大幅减少。单 24Q2，公司综合毛利率为 43.1 ...

Investment Rating - Buy (Maintained) [1] Core Views - Revenue growth driven by pet sector, but veterinary drug profits under pressure [1] - H1 2024 revenue reached 1.099 billion yuan, up 10.56% YoY, while net profit attributable to shareholders decreased by 10.73% YoY to 159 million yuan [1] - Q2 2024 revenue was 566 million yuan, up 2.63% YoY, with net profit attributable to shareholders dropping 26.56% YoY to 72 million yuan [1] - Gross margin declined by 3.46 percentage points due to weak breeding market conditions and intense competition [1] - R&D investment increased to 96.71 million yuan, accounting for 8.80% of revenue, driving product innovation and market expansion [1] Business Performance - Poultry biological products sales reached 490 million yuan, up 14.88% YoY [1] - Pharmaceutical and API business revenue was 480 million yuan, up 2.29% YoY [1] - Pet sector revenue surged over 100% YoY to 34 million yuan, with strong sales of new cat triple vaccine (Rui Miao Shu) exceeding 1 million doses [2] - Expanded distribution channels with over 40 new partners and coverage of more than 5,700 hospital stores, including over 500 Ruipai pet hospitals [2] Financial Forecasts - EPS projected at 1.10, 1.35, and 1.61 yuan for 2024, 2025, and 2026, respectively [2] - Dynamic PE ratios estimated at 11x, 9x, and 7x for 2024, 2025, and 2026 [2] - Revenue growth rates forecasted at 24.02%, 21.89%, and 19.49% for 2024, 2025, and 2026 [3] - Net profit growth rates expected at 12.85%, 23.39%, and 18.88% for the same periods [3] R&D and Product Development - Obtained 8 new veterinary drug certificates, including vaccines and oral solutions [1] - Continued high R&D investment to enhance product quality and expand market share [1] - Future product pipeline includes rabies vaccine, cat quadruple mRNA vaccine, and oral deworming medications [2] Market and Industry Outlook - Pet healthcare market remains a blue ocean with significant growth potential [2] - Industry rating: In-line with the market, expected to perform within -5% to 5% of the relevant market index over the next 6 months [7]

Investment Rating - The report maintains a "Hold" rating for the company [1] Core Views - The company reported a significant increase in gross margin and a substantial growth in net profit for Q2 2024, despite a decline in revenue due to weak downstream demand [1] - The precision reducer segment showed a notable improvement in gross margin, contributing to the overall margin increase [1] - Future profit forecasts indicate a compound annual growth rate (CAGR) of 27% for net profit from 2024 to 2026 [1] Financial Performance Summary - For H1 2024, the company achieved revenue of 505 million yuan, a year-on-year decrease of 6.37%, while net profit attributable to shareholders was 44 million yuan, a year-on-year increase of 30.86% [1] - In Q2 2024, revenue was 283 million yuan, down 11.93% year-on-year but up 26.90% quarter-on-quarter; net profit was 27 million yuan, up 49.25% year-on-year and 65.84% quarter-on-quarter [1] - The gross margin for H1 2024 was 24.54%, an increase of 3.37 percentage points year-on-year, with a net margin of 8.60%, up 2.44 percentage points year-on-year [1] Business Segment Performance - Revenue from the decelerating motor segment was 165 million yuan, down 1.54% year-on-year; precision reducers generated 126 million yuan, up 3.19% year-on-year; and smart execution units brought in 206 million yuan, down 14.52% year-on-year [1] - The gross margin for precision reducers in H1 2024 was 21.38%, an increase of 11.92 percentage points year-on-year, while the gross margin for decelerating motors was 26.66%, down 2.11 percentage points [1] Profit Forecasts - The company is expected to achieve net profits of 95 million yuan, 121 million yuan, and 150 million yuan for the years 2024, 2025, and 2026, respectively, with corresponding EPS of 0.63, 0.80, and 0.99 yuan [2][6] - The projected revenue growth rates for the next three years are 22.41% for 2024, 15.49% for 2025, and 15.19% for 2026 [2][6]

Investment Rating - The report maintains a "Buy" rating for the company, with a current price of 11.85 yuan and a target price not specified for the next six months [1]. Core Insights - The company reported a revenue of 1.099 billion yuan for H1 2024, representing a year-on-year increase of 10.56%. However, the net profit attributable to shareholders decreased by 10.73% to 159 million yuan [1]. - The company is facing challenges due to rising costs in the breeding sector and competitive pressures in the animal health products market, leading to a decline in gross margin by 3.46 percentage points [1]. - The pet segment is showing strong growth, with revenue exceeding 34 million yuan, a growth rate of over 100% year-on-year, driven by new product launches and expanded distribution channels [2]. Summary by Sections Financial Performance - For H1 2024, the company achieved a revenue of 1.099 billion yuan, up 10.56% year-on-year, while the net profit attributable to shareholders was 159 million yuan, down 10.73% [1]. - In Q2 2024, revenue was 566 million yuan, a 2.63% increase year-on-year, but net profit fell by 26.56% to 72 million yuan [1]. - The gross margin decreased due to competitive pressures and cost management issues in the breeding sector [1]. Research and Development - R&D investment reached 96.71 million yuan in H1 2024, accounting for 8.80% of revenue. The company obtained eight new veterinary drug registration certificates [1]. - Continuous high R&D investment is expected to drive product upgrades and innovation, enhancing the company's competitive edge [1]. Pet Segment Growth - The pet segment's revenue grew over 100% year-on-year, with the newly launched cat trivalent vaccine achieving sales of over one million doses [2]. - The company is expanding its distribution network, covering over 5,700 hospital stores and more than 500 pet hospitals [2]. - Future product launches in the pet segment are anticipated to further enhance competitiveness and drive revenue growth [2]. Earnings Forecast - The company is projected to have an EPS of 1.1, 1.35, and 1.61 yuan for 2024, 2025, and 2026, respectively, with corresponding dynamic PE ratios of 11, 9, and 7 times [2].